Skip to main content
Elsevier
View Cart
openUserAccount

Books in Hepatology

BooksJournals
31-40 of 70 results in All results

Acute Liver Failure, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 22-2
  • April 3, 2018
  • Nikolaos T. Pyrsopoulos
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 8 3 6 0 - 2
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 8 3 6 1 - 9
Dr. Pyrsopoulos has assembled the top authors in the field to provide current reviews on acute liver failure, to be the first time this topic is addressed in one volume. Topics are devoted to Classification and Epidemiologic Aspects of Acute Liver Failure; Acute Liver Failure: Mechanisms of disease and multi-systemic involvement; The Pathology of Acute Liver Failure; Liver Regeneration in the Acute Liver Failure Patient; Viral Hepatitis and Acute Liver Failure: Still a Problem; Drug- induced Liver Injury and Acute Liver Failure; Acetaminophen and Acute Liver Failure; Non-Viral Or Drug-Induced Etiologies of Acute Liver Failure; The Clinical Spectrum and Manifestations of Acute Liver Failure; Non ICU Management of Acute Liver Failure; Management of Acute Liver Failure in the ICU Setting; Prognostic Models of Acute Liver Failure; The Role of Liver Transplantation in Acute Liver Failure; and Future Approaches and Therapeutic Modalities for Acute Liver Failure. Readers will come away with a current point of view about how to approach and manage the patient with acute liver failure.

NASH and NAFLD, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 22-1
  • November 19, 2017
  • David Bernstein
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 6 9 8 6 - 6
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 6 9 8 7 - 3
Obesity has devastating effects on a patient's overall health, with specific negative effects on organ systems, long-term. The hepatologist must often manage diseases of the liver and pancreas as a result of obesity. This issue will provide a current update on the diagnosis, treatment, and management of NAFLD and NASH. Dr. Bernstein has assembled the top leaders in the field to provide timely clinical reviews. Articles are devoted to the following topics: Clinical and economic burden of NAFLD/NASH; NAFLD/NASH in children and its implications; Natural history of NAFLD/NASH; Diagnosis and evaluation of NAFLD/NASH; Radiological imaging in NAFLD/NASH; The use of liver biopsy in NAFLD: When to biopsy and in whom; Pathophysiology of NAFLD/NASH; Risk factors for the development of NAFLD/NASH including genetics; Role of intestinal microbes in NAFLD/NASH; NAFLD/NASH and the metabolic syndrome; NAFLD/NASH and lipid and insulin resistance; NAFLD/NASH and cardiac disease; Current treatment of NAFLD/NASH; Emerging treatment of NAFLD/NASH; NAFLD/NASH and HCC and NAFLD/NASH and liver transplantation. Readers will have a clear understanding of how to manage outcomes for these patients.

Consultations in Liver Disease, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 21-4
  • October 11, 2017
  • Steven L. Flamm
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 4 8 8 5 - 4
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 4 8 8 6 - 1
Consultations of Gastroenterology practitioners are frequently sought for many complex issues relating to acute and chronic liver disease. Many of the disease entities are uncommon and complicated in scope. Liver disease may occur in the setting of other chronic medical conditions and involve other organ systems, with recommendations for diagnostic strategies and therapeutic approaches somewhat challenging. Serious consequences are often the rule with misdiagnosed or inadequately treated liver disease. Dr. Flamm has provided a framework for approaching consultation for common liver-related problems for the gastroenterology practitioner. Articles are devoted to the following topics: Common Findings and Interpretation for the Clinician; Genetic Testing in Liver Disease: What to Order and When; Acute Liver Failure; Liver Disease in Oncology Patients; Primary Sclerosing Cholangitis: What the Gastroenterologist/Hepatologist Needs to Know; An Update on the Treatment and Follow up of Patients with PBC; Wilson’s Disease: Diagnosis, Treatment, and Follow Up; Follow Up of the Post-Liver Transplantation Patient: A Primer for the Practicing Gastroenterologist; Liver Disease in Patients on Total Parenteral Nutrition; Treatment Strategies in NAFLD: What’s Coming; Resistance Testing in Chronic HCV; and HCV genotype 3: Treatment Approach and Natural History.

Handbook of Liver Disease

  • 4th Edition
  • August 24, 2017
  • Lawrence S. Friedman + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 3 2 3 - 4 7 8 7 4 - 8
Well-organized and vibrantly illustrated throughout, Handbook of Liver Disease is a comprehensive yet concise handbook providing authoritative guidance on key clinical issues in liver disease. The quick-reference outline format ensures that you’ll find answers when you need them, and cover-to-cover updates keep you abreast of the recent rapid changes in the field. Written by leading international experts in hepatology, this reference is ideal for gastroenterologists, hepatologists, internists, family practitioners, trainees, and others who diagnose and manage patients with liver disorders.

Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 21-3
  • July 11, 2017
  • Zobair M. Younossi
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 3 2 3 9 - 6
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 3 2 4 0 - 2
Dr. Younossi is a highly-esteemed expert in Hepatitis C Virus (HCV), and for the first time in Clinics in Liver Disease, he has compiled articles that specifically address the extrahepatic manifestation of HCV. Articles are specifically devoted to the following topics: Hepatitis C: A Systemic Disease; Rheumatologic Manifestations of HCV; Cardiovascular Manifestations on HCV; Metabolic Manifestations of HCV (DM, Dyslipidemia); Renal Manifestations of HCV; Lymphoproliferative Disorders Associated with HCV; Depression and HCV; Neurologic Manifestations of HCV; Non-HCC Malignancies in HCV; Dermatologic Manifestations of HCV; Fatigue and Patient-reported Outcomes in HCV; Economic Burden of HCV; and Endocrine Manifestations of HCV (non-dabetes). The thorough coverage of systemic issues will give clinicians the information they need to effectively manage the HCV patient with other health issues.

Liver Transplantation, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 21-2
  • April 12, 2017
  • Roberto J. Firpi
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 5 2 8 4 4 - 3
  • eBook
    9 7 8 - 0 - 3 2 3 - 5 2 8 4 5 - 0
Cirrhosis from hepatitis C (HCV) is now the most common indication for liver transplant (LT) in the U.S., but between 2004 and 2013, new LT listings for NASH increased by 170%. Unfortunately, fibrosis progression leading to cirrhosis, liver cancer, and liver decompensation continues to occur after transplantation. Once cirrhosis and decompensation are evident, patient survival is poor and repeat LT is considered to improve outcomes. Therefore, the never-ending thirst for new approaches in the management of patients pre- and post-transplant has led to a very promising future in transplantation, thought there is much to learn to achieve better patient outcomes. This issue of Clinics in Liver Disease addresses the core areas to achieve better patient outcomes, with articles devoted to coagulopathy before liver transplant, challenges in renal failure before LT, LT for acute alcoholic hepatitis, LT in the pregnant patient, bariatric surgery and LT,and MELD Scores in prioritization of LT, to name a few. Readers will place a high value on the current state of liver transplantation in this issue.

Zakim and Boyer's Hepatology

  • 7th Edition
  • February 7, 2017
  • Thomas D. Boyer + 1 more
  • Arun J. Sanyal + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 3 7 5 9 1 - 7
Get the authoritative, up-to-date information you need on liver disease from the 7th Edition of the most trusted reference worldwide. Covering both basic science and recent clinical developments, this revised edition by Drs. Arun J. Sanyal, Thomas D. Boyer, Norah A. Terrault, and Keith D. Lindor, provides an in-depth, comprehensive look at the pathophysiology, diagnostic, and treatment information related to the liver. More than 1,100 figures and tables, many new and in full color, highlight completely updated content throughout.

Understanding Gallstones

  • 1st Edition
  • December 30, 2016
  • Atul Kakar + 1 more
  • English
  • eBook
    9 7 8 - 8 1 - 3 1 2 - 4 9 8 0 - 2
This small book is a part of the patient care series from Elsevier, which is meant for common people to have better understanding of gallstones.

Drug Hepatotoxicity, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 21-1
  • November 16, 2016
  • Vinod K. Rustgi
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 9 6 5 2 - 0
  • eBook
    9 7 8 - 0 - 3 2 3 - 4 9 6 6 2 - 9
Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver Damage including the RUCAM scale; Drug-induced acute liver failure; Epidemiology and genetic risk factors; Adverse drug reactions: type A (intrinsic or pharmacological) or type B (idiosyncratic); Pathology of injury including phenotypes; The clinical course of drug-induced liver disease; Environmental factors of drug hepatotoxicity; Newer agents in drug hepatotoxicity; Drug hepatotoxicity: herbal products; Drug hepatotoxicity: models including “human on a chip” and zebrafish; Acute and chronic liver failure from drugs: impact on the kidney; and Management of acute hepatotoxicity including medical agents and liver support systems. Readers will come away with the cutting edge science behind the latest innovations in the treatment of Hepatitis B.

Hepatitis B Virus, An Issue of Clinics in Liver Disease

  • 1st Edition
  • Volume 20-4
  • October 15, 2016
  • Tarek I. Hassanein
  • English
  • Hardback
    9 7 8 - 0 - 3 2 3 - 4 7 6 8 6 - 7
  • eBook
    9 7 8 - 0 - 3 2 3 - 4 7 7 0 5 - 5
HBV is most prevalent viral infection worldwide. Recent advances in HBV virology epidemiology and management are of utmost importance particularly during this time when HCV is taking the front row in discussion and research. However, there’s an increased interest in management of HBV in special populations, which is covered in this issue. The authors also explore drugs in the pipeline as well as new approaches for achieving long-term viral suppression and possibly cure.